Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

So VeriSign's still-low invested capital supports its high current ROIC. On an adjusted basis, the company's ROIC was 4.4% for 2023, with a five-year average of 3.9%, according to the data provided by ...

Fred Alger Management, LLC ("Alger"), a privately held $27.4 billion growth equity investment manager, today announced the launch of the Alger Russell Innovation ETF (Ticker: INVN), a fully ...

The stock's fall snapped a three-day winning streak.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Artivion, Inc. AORT: This medical device and tissue ...

Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of ...

Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $402.49, demonstrating a -1.13% swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.55%. On ...

International Business Machines Co. (NYSE:IBM – Get Free Report)’s stock price traded up 0.5% during mid-day trading on ...

From beauty to fashion, consumer startups are seeking easy debt to expand inventory and facilitate marketing for quick ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K)-0.50% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L)-0.88% U.S. Bancorp Dep. Pfd ...